— Know what they know.
Not Investment Advice
Also trades as: AJANTPHARM.BO (BSE) · $vol 0M

AJANTPHARM.NS NSE

Ajanta Pharma Limited
1W: +1.2% 1M: +2.2% 3M: +7.7% YTD: +23.9% 1Y: +35.5% 3Y: +111.8% 5Y: +150.5%
₹3,542.70 ($36.80)
-38.30 (-1.07%)
 
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 57 · ₹448.0B mcap · 42M float · 0.270% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹448.0B ($4.7B)
52W Range2379.3-3796
Volume75,747
Avg Volume113,586
Beta0.18
Dividend₹60.00
Analyst Ratings
No analyst coverage
Company Info
CEOYogesh Mannalal Agrawal
Employees10,421
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2002-07-01
Ajanta House
Mumbai, MA 400 093
IN
91 22 6606 1000
About Ajanta Pharma Limited

Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms